Quarterly Consolidated Statement Of Cash Flows

CellSeed Inc. - Filing #7344500

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-845,584,000 JPY
-758,730,000 JPY
Depreciation
7,939,000 JPY
7,891,000 JPY
Impairment losses
112,028,000 JPY
3,490,000 JPY
Interest expenses
1,128,000 JPY
835,000 JPY
Decrease (increase) in trade receivables
-26,095,000 JPY
2,388,000 JPY
Decrease (increase) in inventories
9,974,000 JPY
-14,628,000 JPY
Increase (decrease) in trade payables
3,384,000 JPY
-4,628,000 JPY
Subtotal
-777,465,000 JPY
-713,379,000 JPY
Interest paid
-1,032,000 JPY
-837,000 JPY
Income taxes paid
-948,000 JPY
-3,798,000 JPY
Net cash provided by (used in) operating activities
-779,435,000 JPY
-718,006,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-21,632,000 JPY
-15,590,000 JPY
Net cash provided by (used in) investing activities
56,315,000 JPY
61,728,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-7,500,000 JPY
-1,250,000 JPY
Net cash provided by (used in) financing activities
1,814,201,000 JPY
881,814,000 JPY
Net increase (decrease) in cash and cash equivalents
1,091,081,000 JPY
225,536,000 JPY
Cash and cash equivalents
2,163,292,000 JPY
1,072,210,000 JPY
846,674,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.